Denali Therapeutics Inc (DNLI) earnings · $2.11B cap
These earnings events as JSON? API free 100/dayDenali Therapeutics Inc (DNLI) is a biotechnology company listed on US.
This DNLI earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported DNLI revenue for 2025-12-31 was $0. Net income was -$512.5M. DNLI currently screens at market cap $2.11B.
When the next DNLI 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
Period-over-period revenue change is not in cache for DNLI. We will not invent a beat or miss.
Not investment advice. Full DNLI research stays on the stock page; the tape stays on the quote page.
DNLI earnings FAQ
What is DNLI's latest net income?
Latest cached Denali Therapeutics Inc (DNLI) net income was -$512.5M. Statements: https://lician.com/financials/dnli
What is DNLI's latest diluted EPS?
Latest cached Denali Therapeutics Inc (DNLI) diluted EPS for Dec 31, 2025 was -$2.97.
What period does the latest DNLI earnings print cover?
The latest cached Denali Therapeutics Inc (DNLI) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.
Where are DNLI earnings listed?
Cached earnings facts for Denali Therapeutics Inc (DNLI) are listed at https://lician.com/earnings/dnli. Statements: https://lician.com/financials/dnli
Not investment advice.